SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves sharp selloff is focused on concerns that its debt-funded data-center expansion may be costly to finance and vulnerable if AI demand slows, amplified by HSBCs bearish assessment. Traders are divided between viewing the decline as a buying opportunityciting AI demand, its backlog and bullish analyst callsand warning that financing costs and insider selling pose serious risks.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is drawing attention amid a slide to record lows, which traders associate with fading confidence in Trump ahead of the midterms and concerns about the companys limited operating business. The conversation is overwhelmingly bearish, though some traders point to a possible trading bounce or the pending TAE fusion deal as potential offsets.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Middle East shipping and energy-infrastructure threats, including reported attacks around the Strait of Hormuz and Saudi Arabia, are fueling oil-supply concerns and lifting crude prices, drawing attention to USO, which tracks WTI futures. Traders are divided between betting that further disruption will sustain the rally and expecting a pullback if tensions ease or the supply-risk premium fades.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

Barclays downgrade of NuScale, citing commercial execution risks and delays in securing a definitive TVA/ENTRA1 agreement, is driving the selloff. Traders are split between viewing the concerns as a justified warning about project timelines and seeing the downgrade as an overreaction or an opportunity to buy the beaten-down shares.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USAR is drawing attention after a prolonged selloff toward 52-week lows, alongside weakness across rare-earth and critical-minerals stocks. Traders debate whether the decline reflects sector pressure and concerns about potential dilution, cash burn, and the time needed to reach production; some blame short sellers or management, while others view the shares as oversold and point to the companys strategic U.S. supply-chain role.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicors Q3 results are driving attention, with strong revenue growth and a larger backlog reinforcing optimism about AI-related power-module demand and recurring VPD licensing royalties. Traders are weighing those positives against concerns about the GAAP EPS miss, limited forward outlook and capacity constraints, amid volatile post-earnings trading.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is falling despite a quarterly earnings beat and a new multiyear share-repurchase authorization, as traders focus on a full-year profit outlook whose midpoint was unchanged rather than raised. The community is split between buyers who see strong cash generation and the buyback as support, and skeptics who argue the outlook and sales pressures outweigh those positives.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Morgan Stanleys upgrade of Amazon to a top pick, citing AWS growth potential and AI demand, drove a sharp rally and dominated discussion. Traders were largely bullish, though some questioned whether the move would hold and viewed upcoming earnings and nearby resistance as key tests.

RTX Corp. is an aerospace and defense company, which engages in the provision of aerospace and defense systems and services for commercial, military, and government customers. It operates through the following segments: Collins Aerospace Systems (Collins), Pratt and Whitney, Raytheon Intelligence and Space (RIS), and Raytheon Missiles and Defense (RMD). The Collins segment manufactures and sells aero structures, avionics, interiors, mechanical systems, mission systems, and power controls. The Pratt and Whitney segment includes the design and manufacture of aircraft engines and auxiliary power systems for commercial, military, and business aircraft. The RIS segment is involved in the development of sensors, training, and cyber and software solutions. The RMD segment offers end-to-end solutions to detect, track, and engage threats. The company was founded in 1922 and is headquartered in Arlington, VA.

RTX Corp

Raytheon Technologies Corporation

RTX is drawing attention after quarterly results topped expectations and management raised its full-year outlook, citing strong aerospace and defense demand and a record backlog. Traders broadly welcomed the results but debated why the share-price reaction appeared muted or negative despite the beat and guidance increase.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers push through the closely watched $30 level and fresh 52-week highs is drawing attention, with traders pointing to renewed interest in defensive pharma and recent pipeline and product updates. Bulls see the move as a breakout, while skeptics question whether it can hold above resistance given patent-expiration and growth concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate 

Biotech ETFs offer diversified exposure to oncology innovation as cancer funding surges and the global oncology drug market expands.

The Zacks Analyst Blog Highlights Amgen, Crinetics, FBT, BBH and BBP

Biotech ETFs are riding innovation, obesity drug growth and M&A, offering diversified exposure to the sector???s powerful rally.

Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth 

 Biotech ETFs are riding a powerful rally fueled by innovation, obesity drugs and M&A, with three funds offering diversified exposure to growth.

IBRX Stock In Spotlight As FDA Scrutiny Prompts ImmunityBio To Withdraw Content, Tighten Oversight

Equity

The company said it has responded to the FDA’s Office of Prescription Drug Promotion after receiving a notice on March 13 about its promotional content.


Why Did DAWN Skyrocket Over 65% Pre-Market Today? 

Pharma firm Servier is set to acquire Day One Biopharmaceuticals’ shares for $21.50 each in cash, valuing the deal at $2.5 billion.


Liquidia Stock Gains Premarket On Q4 Revenue Beat – Investors Are Betting On YUTREPIA Growth 

Product revenue from YUTREPIA reached approximately $148.3 million in 2025, including about $90.1 million generated during the fourth quarter alone.


IBRX Stock Reverses Pre-Market Gains After ANKTIVA Combo Shows Stronger Bladder Cancer Responses – Retail Sees Consolidation Before Next Leg Up

The company said it plans to submit a biologics license application by the fourth quarter of 2026.

Biotech ETFs Hovering Around a 52-Week: Here's Why 

Biotech is back! Regulatory tailwinds, cheaper valuations, and Fed cut hopes are boosting ETFs like XBI and IBB. Is the rebound just starting?

Biotech ETFs Bounce Back in 2025: Here's Why  

Biotech ETFs rally. IBB, ARKG, SBIO, BBC, CANC and BBP soar as Fed rate cut optimism, FDA approvals, deals and cheaper valuations drive the space in 2025.

ETFis Series Trust I - Virtus Biotech ETF

Bullish Sentiment

<ul class="summary-bullets"><li>ImmunityBio said it removed the referenced podcast from its website and requested removal from external platforms.</li><li>Enhanced compliance measures will include stricter promotional review protocols and mandatory executive-level training.</li><li>ANKTIVA, ImmunityBio’s interleukin-15-based immunotherapy, remains central to the company’s oncology strategy.</li></ul>ImmunityBio Inc. (IBRX) stated on Monday that it has responded to regulatory concerns raised by the U.S. Food and Drug Administration, outlining corrective steps related to promotional content for its cancer therapy as the company seeks to reinforce compliance standards.The company said it submitted a detailed reply to the FDA’s Office of Prescription Drug Promotion following a March 13 communication on marketing materials, including a podcast and a television advertisement.&nbsp;<h2 class="st-heading-2">FDA Inquiry And ImmunityBio’s Response</h2>ImmunityBio clarified that the advertisement in question was never released to the public and addressed issues tied to statements made in the podcast.&nbsp;In response, ImmunityBio removed the referenced podcast from its website and requested its deletion from external platforms hosting the content.&nbsp;<blockquote>“We are dedicated to maintaining a clear distinction between our investigational pipeline aspirations and the promoted indications for our approved therapies.”-Richard Adcock, President and CEO, ImmunityBio</blockquote>&nbsp;<a href="https://stocktwits.com/symbol/IBRX">ImmunityBio stock</a> traded over 3% higher in Monday’s premarket.&nbsp;On Stocktwits, retail sentiment around the stock remained in ‘bearish’ territory amid ‘low’ message volume levels.&nbsp;<h2 class="st-heading-2">Strengthening Compliance Measures</h2>The Culver City-based firm said it is introducing tighter oversight procedures, including enhanced review protocols for marketing materials, mandatory executive-level compliance training, and the addition of external regulatory advisors to evaluate future communications. These measures are intended to ensure that promotional messaging aligns with FDA standards for accuracy and balance.The podcast in question featured founder Patrick Soon-Shiong, who was discussing long-term scientific ambitions.The company emphasized its commitment to providing clear and compliant information about ANKTIVA, an immunotherapy designed to stimulate key immune cells that target cancer. The treatment builds on the biology of interleukin-15 to enhance the immune response, forming part of ImmunityBio’s broader oncology strategy.IBRX stock has gained over 268% year-to-date.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/slno-stock-soars-over-39-what-s-fueling-the-rally/cZJ4SjzRIoU">SLNO Stock Soars Over 39% — What’s Fueling The Rally?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the ImmunityBio logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

ImmunityBio company said it has responded to the FDA’s Office of Prescription Drug Promotion after receiving a notice on March 13 about its promotional content.

ETFis Series Trust I - Virtus LifeSci Biotech Products ETF

ImmunityBio Inc

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Feed

News

Sentiment

Fundamentals

Info

BBP ETFis Series Trust I - Virtus LifeSci Biotech Products ETF

Fundamentals

Latest BBP News